Description
Orion Health™, a global health technology company at the forefront of the revolution in healthcare, today announced the launch of Amadeus, a platform that will enable highly personalised healthcare and the implementation of Precision Medicine. This signals an expansion of the company's current population health management offering to embrace the newest frontier in healthcare.Orion Health CEO Ian McCrae believes that precision medicine is going to revolutionise decision support for clinicians. “Today, many factors impact health outcomes, yet currently, only a few are taken into account when healthcare decisions are being made. Although massive amounts of medical information exist, clinicians simply don't have the time or capacity to find specific information that is relevant when they have a patient in front of them.”.“If we have our way, clinicians will get the insights they need to help them make accurate diagnoses and provide the optimal treatment. And patients will increasingly have the information they need to be active participants in their own healthcare,” says Mr McCrae.Amadeus is an open data platform built using modern technology that scales to aggregate and manage different types of health data. Orion Health has evolved the platform to accommodate huge data file types, including genomic data, creating an infinitely scalable platform for precision medicine.“What is particularly exciting is that we are delivering Amadeus as an open platform, upon which third parties can innovate. The platform's APIs (Application Program Interfaces) will enable third-party applications to have access to rich data and services so that they can provide additional services that will benefit both doctors and their patients,” said McCrae.Gary Folker, EVP for Orion Health in North America, believes that precision medicine will dramatically change healthcare as we know it. “Current models of population health focus on identifying gaps in care and proactively driving preventive care and early interventions. This represents a tremendous advance in care, but evidence-based preventive measures only address a small percentage of overall illness. The next, and far more impactful, model of care delivery will take into account the genetics, family history, environmental factors and other individual attributes that can predict and guide treatment for the vast majority of care.”“With Amadeus, we will enable our clients to deliver precision medicine with real-time access to all of these new data elements, including massive genomics files and unstructured clinical histories and research,” said Folker.